BiotechTube
Home/Perfuse Therapeutics/Phil Lai, MD
PL

Phil Lai, MD

Chief Medical Officer

Perfuse Therapeutics

Therapeutic Areas

OphthalmologyCardiovascular

Perfuse Therapeutics Pipeline

DrugIndicationPhase
PER-001GlaucomaPhase 2